These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15853431)

  • 1. Meningococcal vaccination: cui bono?
    Szucs TD
    Pharmacoeconomics; 2005; 23(4):315-6. PubMed ID: 15853431
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunisation against meningococcus B.
    Head C
    Lancet; 2013 Sep; 382(9896):935. PubMed ID: 24034290
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis.
    Miller MA; Shahab CK
    Pharmacoeconomics; 2005; 23(4):333-43. PubMed ID: 15853434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The price of prevention: what now for immunisation against meningococcus B?
    Moxon R; Snape MD
    Lancet; 2013 Aug; 382(9890):369-370. PubMed ID: 23911365
    [No Abstract]   [Full Text] [Related]  

  • 5. Do we need a new approach to making vaccine recommendations?
    Crowcroft NS; Deeks SL; Upshur RE
    BMJ; 2015 Jan; 350():h308. PubMed ID: 25637290
    [No Abstract]   [Full Text] [Related]  

  • 6. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness.
    Wise J
    BMJ; 2014 Mar; 348():g2327. PubMed ID: 24665138
    [No Abstract]   [Full Text] [Related]  

  • 8. Should all college-bound freshmen receive meningococcal vaccine?
    Gordon SM
    Cleve Clin J Med; 2001 Jan; 68(1):9-10. PubMed ID: 11204371
    [No Abstract]   [Full Text] [Related]  

  • 9. Costs, compassion, and the case for vaccination.
    Lancet Infect Dis; 2016 Apr; 16(4):385. PubMed ID: 27036333
    [No Abstract]   [Full Text] [Related]  

  • 10. Meningococcal vaccination for college freshmen.
    Bröker M
    Cleve Clin J Med; 2001 Oct; 68(10):879. PubMed ID: 11596625
    [No Abstract]   [Full Text] [Related]  

  • 11. Meningitis B.
    The Lancet
    Lancet; 2013 Aug; 382(9890):368. PubMed ID: 23911364
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunisation against meningococcus B.
    Rappuoli R
    Lancet; 2013 Sep; 382(9896):935-6. PubMed ID: 24034289
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunisation against meningococcus B.
    Blewitt J
    Lancet; 2013 Sep; 382(9895):857-8. PubMed ID: 24012267
    [No Abstract]   [Full Text] [Related]  

  • 14. [Africa: towards the eradication of meningitis A?].
    Nau JY
    Rev Med Suisse; 2011 Jun; 7(300):1378-9. PubMed ID: 21815540
    [No Abstract]   [Full Text] [Related]  

  • 15. Meningococcal meningitis.
    Aguado T; Bertherat E; Djingarey M; Kandolo D; Kieny MP; Kondé K; LaForce FM; Nelson CB; Perea W; Préziosi MP
    Nat Rev Microbiol; 2005 Jan; 3(1):10-1. PubMed ID: 15635779
    [No Abstract]   [Full Text] [Related]  

  • 16. The real cost of an affordable vaccine for meningococcus A.
    Rappuoli R
    Lancet; 2003 Jul; 362(9379):250-1; author reply 251. PubMed ID: 12885501
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost effectiveness has its place, but so does common sense.
    Rappuoli R; Wassil J; Bonefeld L; Porter J
    BMJ; 2014 Nov; 349():g6759. PubMed ID: 25394622
    [No Abstract]   [Full Text] [Related]  

  • 18. Meningococcal disease control in countries of the African meningitis belt, 2013.
    Wkly Epidemiol Rec; 2014 May; 89(20):206-14. PubMed ID: 24864346
    [No Abstract]   [Full Text] [Related]  

  • 19. [Against meningococcus: a new form of vaccination].
    Triau R; Merieux C
    Bull Acad Natl Med; 1979 Mar; 163(3):277-88. PubMed ID: 15672589
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential long term vaccine benefits poorly translate in cost effectiveness modelling.
    Black S
    BMJ; 2014 Nov; 349():g6764. PubMed ID: 25394571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.